Navigation Links
Johns Hopkins University Applied Physics Lab Group Joins OrthoCare Innovations
Date:6/3/2009

OKLAHOMA CITY, June 3 /PRNewswire/ -- OrthoCare Innovations is pleased to announce the addition of Johns Hopkins Applied Physics Laboratory (APL) researchers Stuart Harshbarger, in the role of Chief Scientific Officer, and Matthew Kozlowski Ph.D., as Director of Robotic Systems.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090603/DA26807)

A member of the principal professional staff at APL, Mr. Harshbarger has served as program manager and systems supported integrator for over $100 million in federally supported research over the past four years. His portfolio included the Defense Advanced Research Projects Agency (DARPA) sponsored Revolutionizing Prosthetics 2009 Program. Mr. Harshbarger will continue to serve as Principal Investigator on the DARPA program in his capacity with OrthoCare, and will maintain an affiliation with Johns Hopkins University through an appointment as a Principal Research Scientist in the Department of Electrical and Computer Engineering.

In his DARPA role, leading what is arguably the largest and most ambitious domestic prosthetic research and development initiative in many decades, Mr. Harshbarger and his team have been widely recognized for their work with awards including: the 2009 IEEE/EE Times Creativity in Electronic Design Award, the "2009 Technology Winner" by the IEEE Spectrum Magazine and the 2007 Popular Mechanics Technology Breakthrough Award.

"I am honored to be joining the OrthoCare Innovations team. Having worked closely with the Company as both a Scientific Advisory Board Member and a customer, I have been consistently impressed with both the talent and personal commitment of the OrthoCare staff to improving the state of rehabilitation technologies and quality of life outcomes," commented Mr. Harshbarger. "I am excited to be able to play a key role in the growth of the Company, while also maintaining my close collaboration with my colleagues at Johns Hopkins, to affect the transition of emerging dual-use technologies from the research laboratory into clinical practice."

"The addition of this world-class talent led by Stuart Harshbarger is a testament to the quality and strength of our team, our technologies and our strategic vision," commented OrthoCare CEO Doug McCormack. "This additional capacity will enhance OrthoCare's ability to execute on its business plan and make a significant contribution to the field."

Joining Mr. Harshbarger is Dr. Matthew Kozlowski, a lead engineer in the biomedicine and National Security Technology groups at APL. Dr. Kozlowski, who received his Ph.D. in Mechanical Engineering from Duke University, has played a key role in the DARPA Revolutionizing Prosthetics 2009 Program. His current work in the area of robotics includes the development of advanced dexterity for future ground explosive ordnance disposal robot systems. He also leads the common architecture and overall systems engineering efforts for the Navy's Advanced Explosive Ordnance Disposal Robot Systems.

About OrthoCare Innovations

OrthoCare Innovations is a medical device research and product development company focused on bringing to market advanced, innovative technologies to improve clinical efficiency and enhance the quality of patient care services in the rehabilitation, prosthetic and orthotic markets. For more information, go to www.orthocareinnovations.com.


'/>"/>
SOURCE OrthoCare Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
2. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
3. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
4. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
5. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
6. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
7. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
8. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
9. Johnson & Johnson to Webcast Annual Meeting of Shareholders
10. Johnson & Johnson Reports 2009 First-Quarter Results:
11. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... Rosa, CA (PRWEB) , ... June 25, 2017 , ... ... more green and growing foliage and plants, and along with that; a humdinger of ... sensitive allergy sufferers, it also means an increase in misery-causing grass and weed pollen. ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ ... Bayfront and Erie Convention Center on June 8-10. The weekend consisted of ... bowl, award and scholarship presentations, and professional networking. , On Friday June ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The ... will ultimately do significant harm to people with all chronic conditions, including mental ... it leaves in place the Affordable Care Act (ACA) requirement that insurers cover ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... plastic surgeon practicing in Newburgh, New York, has recently begun offering three new ... to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... cooking is essential, and two new videos highlight the importance of correctly using ... Christine Bruhn, Ph.D., who has done extensive research on consumer food safety habits. ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: